Searched for
NEW DRUG APPROVAL TIMELINES INDIA
SIS approves share buyback of up to Rs 120 crore. Check detailsSIS has approved a proposed Rs 120 crore share buyback at a maximum price of Rs 478.50 per share, its fifth since listing. The move could l...- Alembic Pharmaceuticals gets USFDA nod for generic acne treatment gelAlembic Pharmaceuticals has secured final USFDA approval for its generic Dapsone gel, a topical treatment for acne vulgaris. This approval,...
- 'Pan masala, gutka will be banned if even traces of intoxicants found': Karnataka CM DK ShivakumarKarnataka Chief Minister DK Shivakumar has issued a strong warning against the sale of pan masala and gutka mixed with intoxicating substan...
- Anchor investors clear path for SP Group's refinancingShapoorji Pallonji Group's anchor investors, including global funds, have agreed to extend relaxed loan-to-value ratios on pledged securiti...
- Vice President Radhakrishnan urges collective action to build drug-free IndiaVice President C.P. Radhakrishnan has called for a nationwide, collaborative effort to combat substance abuse, emphasizing the crucial role...
- Karnataka CM Shivakumar warns of ban on pan masala, gutka containing narcotic substancesKarnataka Chief Minister D K Shivakumar has vowed to ban pan masala and gutka if found laced with intoxicating substances, warning manufact...
- Health ministry proposes faster approvals for medical device manufacturing licencesThe Union health ministry is proposing to significantly cut down the time taken to issue manufacturing licenses for medical devices. Aimed ...
- Myanmar overtakes Afghanistan as top illicit opium source; NCB flags India riskMyanmar has become the world's top source of illicit opium, surpassing Afghanistan due to its ongoing civil war and economic crisis. This s...
- Chhattisgarh: NCL OKs new phase of diamond explorationNMDC-CMDC Limited's board has greenlit the next exploration phase for the Baloda-Belmundi Diamond Block in Chhattisgarh. This crucial step ...
- Cabinet Secretariat cracks down on red tape, orders faster clearances for Centre's key projectsThe Cabinet Secretariat is pushing for faster government processes and reduced red tape to expedite key central projects. New directives ai...
- Alembic Pharma gets USFDA nod for generic influenza treatment drugAlembic Pharmaceuticals has secured USFDA approval for its generic oseltamivir phosphate oral suspension, a key treatment for influenza. Th...
- Govt to amend NDPS Act to plug loopholes exploited by narco syndicates: Amit ShahUnion Home Minister Amit Shah announced plans to amend the NDPS Act to combat drug syndicates, emphasizing a strict approach against peddle...
- Lupin gets USFDA tentative approval for prostate cancer treatment drugIndian pharmaceutical giant Lupin Ltd has secured tentative approval from the US FDA for its generic enzalutamide tablets, a crucial treatm...
- ED arrests prime accused Harpreet Talwar in 3000 kg Mundra port Heroin seizure caseEnforcement Directorate has arrested Harpreet Singh Talwar, a key figure in a money laundering probe linked to a massive heroin seizure at ...
- CDSCO asks states, port offices to step up screening to curb imports of illegal drugsIndia's drug regulator is intensifying border screenings to block unapproved medicines from entering the country. Authorities are cracking ...
- Centre set to tighten oversight of pharma packaging materialsIndia is set to implement a mandatory registration for printed pharmaceutical packaging manufacturers to combat counterfeit drugs. This mov...
- RBI expands digital fraud protection, introduces compensation for small-value scam victimsThe RBI has expanded customer protection rules for digital payment frauds to cover cases where people are tricked into sending money to sca...
- Indian pharma firms gear up to supply key cancer drug to USIndian drugmakers are stepping up to help the US combat a critical shortage of ifosfamide injection, a vital chemotherapy drug. Leading com...
- Biosimilars and innovation will drive Indian pharma's next growth phase: Vishal ManchandaIndia's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...
- Alembic Pharma gets tentative nod from USFDA for generic cancer drugAlembic Pharmaceuticals has secured tentative approval from the USFDA for its generic Binimetinib tablets. This marks a significant step fo...
Load More
